Betamethasone sodium phosphate

Betamethasone sodium phosphate (CAS No.: 151-73-5) is a synthetic glucocorticoid corticosteroid widely employed as a reference and mechanistic probe in inflammation related biomedical research, particularly in studies of fibroproliferative and autoimmune associated disease biology, where it is used to examine glucocorticoid responsive transcriptional programs and immune cell state transitions; as a water soluble phosphorylated derivative of betamethasone, it is generally categorized within small molecule immunopharmacology tools for steroid receptor signaling research, with primary activity mediated through glucocorticoid receptor engagement followed by modulation of NF kappa B and AP 1 linked gene expression networks, suppression of pro inflammatory cytokine secretion, and reported promotion of macrophage polarization from M1 like to M2 like phenotypes in experimental systems relevant to keloid and rheumatoid arthritis associated inflammation models; consistent with this mechanism class, in vitro effects are commonly characterized at nanomolar to micromolar concentration ranges depending on cell type, stimulation context, and assay endpoint, while quantitative potency values vary across platforms and should be interpreted within study specific controls; in practical use, this compound is frequently incorporated into cell based cytokine release assays, macrophage differentiation and polarization workflows, fibroblast and extracellular matrix remodeling studies, and selected in vivo inflammation models to benchmark steroid responsive pathways or to support comparative drug screening designs, and the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.